TxTRA Call for Abstracts
TxTRA is now accepting abstracts for oral presentations and poster exhibits for our first in-person educational conference since 2019! We want to shine a light on the exceptional work of all of you as oncology professionals, and the excellent work of your cancer programs. Abstracts should include a title, three learning objectives, a brief description, and a short presenter bio for both oral and poster presentations.
The deadline to submit is June 30, 2022. All submissions will be reviewed and acknowledged by the 2023 Program & Education Committees. Please consider sharing your expertise with the cancer registry community! Questions? E-mail: programchair@txtra.org.
Poster and Oral Presentation Ideas
COVID-19: Detail the impact on cancer patients, data collection, registry operations, and/or program management related to the pandemic in your facilities.
Abstracting and Coding: Provide advanced-level training on specific, hands-on cases highlighting difficult abstracting and coding issues for specific disease sites including utilization of registry resources in everyday practice. Review common errors and how to address them.
Cancer Advancements and Treatments: Provide updates on advances in the field of oncology and how they have impacted the work of the cancer registry and cancer programs.
Commission on Cancer Standards: Provide advanced-level updates on the accreditation programs of CoC, RCRS, best practices for managing the cancer registry and certified cancer programs.
Data Quality: Share your successes and challenges in quality improvement in your cancer program.
Registry Management: Share how you addressed challenges in registry management including topics like remote operations, budget processes, advocating for the registry, staffing and tips for recruiting and retaining registrars.
Professional Development: Help others in the registry field learn new skills, advance in their career, and reach their professional goals.
Central Registries: Familiarize registrars with the work of the central registry including the importance of quality data, the movement of data from their registry to end users including researchers, epidemiologists, and public health officials, and explain how that data is being used to reduce the burden of cancer. Explore successes at the central registry level attained through the work of registrars throughout the state. Explain the use of data linkages to address gaps in quality and completeness. Address advances in the work of the central registry.
Other ideas? Know a physician or cancer committee member who works with the registry or uses our data who might be interested in presenting? Please submit them.